Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies-Reference-Cited by-同舟云学术

Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies

Published:2011-03-01 Issue:17 Volume:117 Page:4049-4059
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kauh John,Chanel-Vos Chantal,Escuin Daniel,Fanucchi Michael P.,Harvey R. Donald,Saba Nabil,Shin Dong M.,Gal Anthony,Pan Lin,Kutner Michael,Ramalingam Suresh S.,Bender Laura,Marcus Adam,Giannakakou Paraskevi,Khuri Fadlo R.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26004/fullpdf

Reference48 articles.

1. Farnesyltransferase inhibitors versus Ras inhibitors;Gibbs;Curr Opin Chem Biol,1997

2. Farnesyl transferase inhibitors as anticancer agents;Haluska;Eur J Cancer,2002

3. The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity;Basso;J Biol Chem,2005

4. Ras oncogenes in human cancer: a review;Bos;Cancer Res,1989

5. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung;Slebos;N Engl J Med,1990

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of protein prenylation;Biomedicine & Pharmacotherapy;2023-08

2. Cholesterol metabolism in prostate cancer;Prostate Cancer Metabolism;2021

3. CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma;British Journal of Cancer;2020-09-24

4. Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer;Clinical Cancer Research;2020-04-22

5. Exploring the putative self-binding property of the human farnesyltransferase alpha-subunit;FEBS Letters;2017-10-11